Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Growth Hormone Releasing Factor, GRF (1 - 40), amide, human
Growth Hormone Releasing Factor, GRF (1 - 40), amide, human
CAS No. ———
Growth Hormone Releasing Factor, GRF (1 - 40), amide, human( ——— )
Catalog No. M41193 CAS No. ———
Growth Hormone Releasing Factor, GRF (1 - 40), amide, human
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGrowth Hormone Releasing Factor, GRF (1 - 40), amide, human
-
NoteResearch use only, not for human use.
-
Brief DescriptionGrowth Hormone Releasing Factor, GRF (1 - 40), amide, human
-
DescriptionGrowth Hormone Releasing Factor, GRF (1 - 40), amide, human
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight4543.14
-
Molecular FormulaC194H318N62O62S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
UNC8153 TFA
UNC8153 TFA is a selective and potent NSD2 protein degrader with anticancer activity.UNC8153 TFA induces NSD2 degradation in MM.1S multiple myeloma cells and inhibits the proliferation of MM.1S cells.
-
Demethoxydeacetoxyps...
Demethoxydeacetoxypseudolaric acid B's the metabolic reaction of TDA in vivo is mainly occurred in blood and contributes to be the hydrolysis of plasma esterase to ester bond, as well as the glucosylation reaction.
-
Lucidumol A
Lucidumol A has relatively good effect against aldose reductase with IC50 of 19.1uM. Lucidumol A has cytotoxic activity, it reduced cell growth in three human carcinoma cells (Caco-2, HepG2, and HeLa cells) dose dependently with LC50s from 20.87 to 84.36 uM.
